Diagnostic Accuracy of Dengue NS1 Lateral Flow Immunoassay in Comparison to Reverse Transcriptase Polymerase Chain Reaction and Enzyme Linked Immunosorbent Assay.
Dengue NS1 Antigen
Dengue viral strains
ELISA
Lateral flow immunoassay
RT-PCR
Journal
Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839
Informations de publication
Date de publication:
26 Jun 2024
26 Jun 2024
Historique:
received:
02
02
2024
revised:
20
06
2024
accepted:
23
06
2024
medline:
29
6
2024
pubmed:
29
6
2024
entrez:
28
6
2024
Statut:
aheadofprint
Résumé
The most widely used invitro diagnostic qualitative screening method for dengue virus infection is the lateral flow immunoassay technique. Testing of dengue non-structural antigen NS1 offers specificity in determining the active infection while testing of IgM and IgG helps in differentiating the primary and secondary dengue infections. The ELISA functions as the golden standard for dengue testing and PCR credits for the most accurate determination tool at the genetic level. The RT-PCR endorsed NS1 gene and in ELISA or LFIA NS1 antigen is used as the marker owing to the specificity and lesser chances of mutation effects. This study evaluated the performance of AG-Q Dengue NS1 LFIA kit in comparison with RT-PCR quantification cycle (Cq) Values and ELISA NS1 quantitation. The study also focused on differentiating the samples among dengue serotypes using the RealStar Dengue Type RT-PCR Kit 1.0. Dengue serotype 2 is the prominent viral strain in Kerala region succeeded by serotype 3 and 1 with a prevalence rate of 64%, 20% and 6% respectively. Dengue serotype 4 was not reported during this study period. 10% co-infection with DENV 1 & DENV 2 was also reported. The AG-Q Dengue NS1 kit stood as efficient in screening by providing positive results with samples having RT-PCR Cq values up to 43 and ELISA NS1 quantification minimum of 14 Panbio units.
Identifiants
pubmed: 38942174
pii: S0166-0934(24)00115-0
doi: 10.1016/j.jviromet.2024.114991
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114991Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Conflict of interest The AG-Q Dengue NS1 antigen kit development and performance evaluation were conducted at the research and development division of Agappe Diagnostics Limited under the supervision of the first author Mr. Ajaikumar Sukumaran. All other authors declare that there is no conflict of interest.